1 |
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
56
6
|
Gregory AP...Fugger L
|
22801493 |
2012 |
2 |
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.
56
|
De Jager PL...Oksenberg JR
|
19525953 |
2009 |
3 |
Linkage analysis in multiple sclerosis of chromosomal regions syntenic to experimental autoimmune disease loci.
56
|
Xu C...Hillert J
|
11436128 |
2001 |
4 |
Matching and accepting assistive technology in multiple sclerosis: A focus group study with people with multiple sclerosis, carers and occupational therapists.
61
|
Squires LA...Morrison VL
|
27852887 |
2019 |
5 |
Intrathecal Autologous Bone Marrow-Derived Hematopoietic Stem Cell Therapy in Neurological Diseases.
61
|
Zakerinia M...Ramzi M
|
30863518 |
2018 |
6 |
[Effectiveness and safety of rituximab for children with autoimmune diseases of the nervous system].
61
|
Fu Z...Chen Y
|
28881516 |
2017 |
7 |
The zoonotic potential of Mycobacterium avium ssp. paratuberculosis: a systematic review and meta-analyses of the evidence.
61
|
Waddell LA...McEWEN SA
|
25989710 |
2015 |
8 |
Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis.
61
|
Martinez-Hernandez E...Dalmau J
|
25506781 |
2015 |
9 |
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.
61
|
Jara M...Rabinowicz AL
|
26719727 |
2015 |
10 |
Co-existence of neurofibromatosis type 2 and multiple sclerosis: A case report.
61
|
Naghshineh H...Minagar A
|
25876477 |
2014 |
11 |
Pain is associated with prospective memory dysfunction in multiple sclerosis.
61
|
Miller AK...Woods SP
|
25338929 |
2014 |
12 |
An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain.
61
|
Onouchi K...Yoshiyama T
|
25114584 |
2014 |
13 |
Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study.
61
|
Patti F...COGIMUS Study Group
|
24137499 |
2013 |
14 |
Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany.
61
|
Wefer B...Pannek J
|
19693509 |
2010 |
15 |
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.
61
|
Kappos L...BENEFIT Study Group
|
19748319 |
2009 |
16 |
Demonstration of spinal cord and nerve root abnormalities by diffusion neurography.
61
|
Tsuchiya K...Nitatori T
|
18379319 |
2008 |
17 |
Multiple sclerosis: interferon beta for some serious forms.
61
|
|
18092425 |
2007 |
18 |
Leukaemia due to mitoxantrone.
61
|
|
17724842 |
2007 |
19 |
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
61
|
Goodin DS
|
17000997 |
2006 |
20 |
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
61
|
Kinkel RP...CHAMPIONS Study Group
|
16436649 |
2006 |
21 |
Brain cytokines and disease.
61
|
Plata-Salaman CR
|
26984574 |
2002 |
22 |
Diagnostic potential of mitochondrial DNA assessment in patients with optic neuropathy.
61
|
Feng X...Ohba N
|
11776061 |
2000 |
23 |
Non-compressive myelopathy: clinical and radiological study.
61
|
Prabhakar S...Das CP
|
10625902 |
1999 |
24 |
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.
61
|
Filippi M...Comi G
|
9798753 |
1998 |
25 |
MRI demonstration of Wallerian degeneration in various intracranial lesions and its clinical implications.
61
|
Sawlani V...Kohli A
|
9077505 |
1997 |
26 |
A controlled study of reliability and validity of MRI findings in neuro-Behçet's disease.
61
|
Coban O...Yazici H
|
8738085 |
1996 |
27 |
[The clinical diagnostic value of studies using magnetic stimulation].
61
|
Hageman G...Tel-Hampsink J
|
8255340 |
1993 |
28 |
Lack of JC viral genomic sequences in multiple sclerosis brain tissue by polymerase chain reaction.
61
|
Buckle GJ...Asher DM
|
1335225 |
1992 |
29 |
Serum antibodies to HTLV-I in Thai patients with chronic progressive myelopathy, multiple sclerosis, myopathy and in HIV-seropositive intravenous drug abusers.
61
|
Hemachudha T...Phanthumchinda K
|
2751768 |
1989 |
30 |
[Anti-neurofilament antibodies in slow infections of the nervous system].
61
|
Zavalishin IA...Niiazbekova AS
|
3376639 |
1988 |
31 |
Dysfunction of the detrusor and urethra in multiple sclerosis: the role of drug therapy.
61
|
Awad SA...Kiruluta HG
|
6123379 |
1982 |
32 |
Use of the Pulfrich pendulum for detecting abnormal delay in the visual pathway in multiple sclerosis.
61
|
Rushton D
|
1148820 |
1975 |
33 |
[Multiple sclerosis. 5. Cytologic changes in the cerebrospinal fluid].
61
|
Sornas R
|
5452189 |
1970 |